Clinician
Moment
After washing, it pulls.
After washing, it pulls.
What to say, what to ask, and when to go sooner. This page does not diagnose or prescribe.
This page does not diagnose or prescribe. It is a prompt sheet you can take to a clinician you already trust. MenoDerm cannot book an appointment and does not recommend starting, stopping, or changing HRT or any other treatment.
Say
Bring the ordinary details. They matter more than a paper.
- “After I wash, my skin feels tight / stingy / papery.”
- When it started, and whether that lined up with menstrual change, a new medicine, or a new product.
- Where it happens (face, neck, body) and whether it itches, cracks, bleeds, or stings.
- What you already stopped, started, or use every night.
- Any prescribed creams, hormones, or other treatments you are already on. Do not change them from this site.
You can mention that you read an educational summary of Kendall et al., Sci Rep. 2022;12:21715 (stratum corneum ceramides after menopause). That is context, not a diagnosis you are asking them to confirm.
- I am reading Imokawa 1989 (Arch Dermatol Res) and Imokawa 1986 (J Invest Dermatol): experimental forearm surfactant and acetone/ether models. Not menopause studies.
- The claim I care about is: SDS and solvent lipid strip impair stratum corneum water-holding; restoring SC intercellular lipids recovers conductance better than sebaceous-rich lipids; the 1986 ceramide fraction performed best among fractions tested.
- 1989: six healthy men; 5% SDS; Kao affiliation. 1986: short JID report; ceramide versus other fractions in a lab vehicle. Volunteer n for 1986 is not in the abstract.
- I already know Kendall (menopause ceramide/TEWL on buttock). I am not asking for a cream from MenoDerm (there is none).
Ask
- Could this be barrier dryness, irritant dermatitis, or something else that should be examined?
- Which of my current products or actives should I pause while we sort this?
- Do I need a dermatology referral, patch testing, or a prescription emollient?
- How should I think about hormones and skin without changing HRT from a webpage?
- They measured barrier lipids on buttock, not face.
- Separate studies show face and body barrier differ (water loss, cell size). Does that change how we read my face symptoms?
- These pages cite Imokawa 1989/1986 experimental barrier models (non-menopause-specific). How should I place surfactant strip and ceramide-fraction recovery next to menopause-related dryness counseling?
- How do you separate “ceramide function in the mortar” from OTC label claims that just say ceramide?
- How do you put Imokawa next to Kendall’s buttock lipidomics without overclaiming a menopause cream trial?
Must not
This copy must not prescribe a brand, sell a cream, start or stop HRT, pitch ceramide SKUs, invent a menopause link, diagnose from this copy, or use SisLuna / Payot product language.
Go sooner
Contact a clinician promptly (same day or urgent care if that is what is available) for a spreading rash, pus, fever, painful cracking, bleeding, or new involvement of the eyes, genitals, or large areas of skin. Seek emergency help now for trouble breathing, swelling of the lips, tongue, or throat, faintness, severe eye pain or vision changes, blistering, or rapidly worsening skin. If you think a prescribed cream or hormone therapy is involved, contact the prescriber promptly; do not change it from this site.
Do not wait on a “tonight’s order” if those are present.
Sources
- Kendall AC, Pilkington SM, Wray JR, Newton VL, Griffiths CEM, Bell M, Watson REB, Nicolaou A. Menopause induces changes to the stratum corneum ceramide profile, which are prevented by hormone replacement therapy. Sci Rep. 2022;12:21715. doi:10.1038/s41598-022-26095-0
- Gorcea M, Lane ME, Moore DJ. Int J Cosmet Sci. 2019;41:613-616. doi:10.1111/ics.12568
- Mohammed D, Matts PJ, Hadgraft J, Lane ME. AAPS J. 2012;14:806-812. doi:10.1208/s12248-012-9400-3
- Imokawa G, Akasaki S, Minematsu Y, Kawai M. Arch Dermatol Res. 1989;281:45-51. doi:10.1007/bf00424272
- Imokawa G, Akasaki S, Hattori M, Yoshizuka N. J Invest Dermatol. 1986;87:758-761. doi:10.1111/1523-1747.ep12456950